Papers of Dr. Jonas Salk, noted physician, virologist, humanitarian, and founder of the Salk Institute for Biological Studies in San Diego, California. Salk is best known for his development of the world's first successful vaccine for the prevention of poliomyelitis, licensed in the U.S. in 1955. He also conducted important research in the prevention and treatment of influenza, multiple sclerosis, cancer, and acquired immune deficiency syndrome (AIDS). The Salk Papers constitute an exhaustive source of documentation of Dr. Salk's professional activities, but very few materials relating to his personal life. Most of the papers cover the period from the mid-1940s to the 1980s. The papers include extensive general correspondence, files relating to polio, subject files, writings by Dr. Salk, photographs, sound recordings, records of the Salk Institute, and other research materials.

Jonas Salk is best known for his discovery of the world's first successful vaccine for the prevention of poliomyelitis. In addition to this accomplishment, Dr. Salk has made significant contributions to the study, prevention, and treatment of influenza, multiple sclerosis, cancer, and other diseases. He is also known for the founding and direction of the Salk Institute for Biological Studies in San Diego, his work for a wide variety of humanitarian endeavors, and most recently for his involvement in AIDS research.

389 Linear feet (847 archives boxes, 12 cartons, 59 card file boxes, 28 flat boxes, 66 art bin items, 8 map case folders, and 2 films)

Publication rights are held by the creator of the collection.

Material in Series 2), 13), 22) and 26) (primarily POLIO files) may be restricted due to personally identifiable medical information. Access requires advance approval by the director of Special Collections & Archives. Series 24) DAILY NOTES is restricted by donor agreement. Original materials deemed too fragile for use may be restricted. Original media formats are restricted. Viewing/listening copies may be available for researchers.